Actively Recruiting
Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma
Led by Costantino Errani · Updated on 2025-12-15
250
Participants Needed
1
Research Sites
114 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
From the archives of the Rizzoli institute all patients (approximately 750) treated for bone metastases from 01/01/2010 to 31/12/2022. A review will be made from the medical records, radiological imaging, and histological data of these patients
CONDITIONS
Official Title
Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age �3E= 18 years
- Diagnosis of bone metastasis from carcinoma, regardless of carcinoma type, number, or location of metastases
- Availability of imaging and clinical data
- At least one follow-up available within the last 12 months from diagnosis
You will not qualify if you...
- Not meeting at least one of the inclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Istituto Ortopedico Rizzoli
Bologna, Emilia-Romagna, Italy, 40134
Actively Recruiting
Research Team
C
Costantino Errani, MD
CONTACT
R
Roberta Laranga, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here